Celcuity Inc. (CELC) - Dilution Analysis

10-K filing | 46.8M shares outstanding

8-K filing: Celcuity Inc. entered into the Third Amendment to Amended and Restated Loan and Security Agreement with Oxford Finance LLC and Innovatus Life Sciences Lending Fund I, LP, and issued warrants to purchase 50,537 shares of the company's common stock to Innovatus, Oxford, and certain of its affiliates.

10-Q filing | 43.7M shares outstanding

8-K filing: Celcuity Inc. completed a public offering of $201,250,000 aggregate principal amount of 2.750% Convertible Senior Notes due 2031, including the exercise of the underwriters' over-allotment option. ($194.5M proceeds)

10-Q filing | 37.9M shares outstanding

10-K filing | 39.4M shares outstanding

S-3/A filing: This is an S-3/A filing, which relates to the registration of securities under the Securities Act of 1933. It includes undertakings related to liability, incorporation by reference, indemnification, and the eligibility of the trustee.

10-Q filing | 37.1M shares outstanding

S-3 filing: Celcuity Inc. files an S-3 registration statement for mixed shelf offering of common stock, preferred stock, warrants and debt securities for a total proposed amount of $400,000,000.

10-Q filing | 38.4M shares outstanding

8-K filing: Celcuity Inc. completed an offering of 3,871,000 shares of common stock at $15.50 per share, resulting in net proceeds of approximately $56.2 million for the company. ($60.09M proceeds)

10-Q filing | 33.6M shares outstanding

10-K filing | 30.5M shares outstanding

8-K filing: Celcuity Inc. sold 1,034,500 shares of common stock at $14.50 per share on December 1, 2023, generating gross proceeds of $15 million. ($15.0M proceeds)

S-3/A filing: This S-3/A filing, dated 2023-11-22, includes a specimen certificate representing shares of common stock for Celcuity Inc, incorporated by reference to a previous filing on Form S-1/A from 2017-09-12.

S-3 filing: Registration of resale of common stock issuable upon exercise of warrants held by selling stockholders.

10-Q filing | 22.1M shares outstanding

8-K filing: Celcuity Inc. completed a private placement on October 20, 2023, selling pre-funded warrants to purchase up to 5,747,787 shares of common stock at a purchase price of $8.699 per share, resulting in gross proceeds of approximately $50 million. ($50.0M proceeds)

10-Q filing | 22.0M shares outstanding

10-Q filing | 21.7M shares outstanding

10-K filing | 21.7M shares outstanding

S-3 filing: This prospectus relates to the resale of up to 24,347,754 shares of common stock by selling stockholders.

10-Q filing | 14.9M shares outstanding

8-K filing: Celcuity Inc. amended a warrant with Craig-Hallum Capital Group LLC, reducing the number of shares issuable upon exercise from 138,000 to 70,000 and extending the exercise period to September 19, 2025.

10-Q filing | 14.9M shares outstanding

8-K filing: Celcuity Inc. amended its Loan and Security Agreement with Innovatus, increasing the term loan facility to $75 million, and Innovatus has the right to convert up to $6.6 million of outstanding principal into Company common stock at $10.00 per share until August 9, 2025.

10-Q filing | 14.9M shares outstanding

10-K filing | 14.9M shares outstanding

S-3 filing: Celcuity Inc. files an S-3 form for a shelf registration of common stock, preferred stock, warrants and debt securities worth up to $150,000,000.

10-Q filing | 14.9M shares outstanding

10-Q filing | 12.7M shares outstanding

8-K filing: Celcuity Inc. entered into an Underwriting Agreement for the issuance and sale of 2,250,000 shares of common stock at $25.00 per share, with an option for the Underwriters to purchase an additional 337,500 shares. ($56.25M proceeds)

10-Q filing | 10.3M shares outstanding

S-3 filing: The filing is for a shelf registration of common stock, preferred stock, warrants and debt securities for a total aggregate offering price of $100,000,000.

8-K filing: Celcuity Inc. entered into a Purchase Agreement with Craig-Hallum Capital Group LLC for the issuance and sale of 1,714,000 shares of common stock at $14.00 per share, with an option for the underwriter to purchase an additional 257,100 shares. ($24.0M proceeds)

10-K filing | 10.3M shares outstanding

10-Q filing | 10.3M shares outstanding

10-Q filing | 10.3M shares outstanding

10-Q filing | 10.3M shares outstanding

10-K filing | 10.3M shares outstanding